Australia markets closed

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
8.14+1.38 (+20.41%)
At close: 04:00PM EDT
7.70 -0.44 (-5.41%)
After hours: 06:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Cash flows from operating activities
Net income
-22,260
-22,260
-19,085
-12,890
Stock-based compensation
4,705
4,705
1,707
1,892
Change in working capital
1,601
1,601
3,819
1,494
Accounts payable
-139
-139
1,851
-
Other working capital
-15,954
-15,954
-13,559
-9,504
Net cash provided by operating activities
-15,954
-15,954
-13,559
-9,504
Cash flows from investing activities
Net cash used for investing activities
0
0
0
0
Cash flows from financing activities
Common stock issued
5,289
5,289
31,879
0
Other financing activities
-1,394
-1,394
-4,069
-
Net cash used provided by (used for) financing activities
15,087
15,087
27,810
15,246
Net change in cash
-867
-867
14,251
5,742
Cash at beginning of period
19,993
19,993
5,742
0
Cash at end of period
19,126
19,126
19,993
5,742
Free cash flow
Operating cash flow
-15,954
-15,954
-13,559
-9,504
Free cash flow
-15,954
-15,954
-13,559
-9,504